Canopy Growth Corp (CGC) KPIs and segments
Close on Nov 17, 2026Market cap $224.80MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Canopy Growth's business
Canopy Growth's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Canopy Growth's fiscal year ends March 31 — Q1 FY27 = CQ2 2026 (calendar quarter).
| Add to chart | Metric | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Canada Cannabis(C$M) | 65.1 | 51.6 | 50.9 | 5.70 | 14.6 | 49.7 | 45.4 | 46.1 | 38.6 | 40.4 | 40.3 | ||
Cannabis Net Revenue(C$M) | 65.1 | 54.5 | 51.6 | 50.9 | 57.0 | 45.5 | 49.7 | 45.4 | 46.1 | ||||
Canadian Medical Cannabis Net Revenue(C$M)2 | 16.3 | 15.6 | 15.0 | ||||||||||
Canadian Adult-use Cannabis(C$M) | 29.7 | 20.6 | 22.9 | 23.9 | 27.0 | 20.4 | 21.2 | 18.4 | 18.9 | 21.0 | 23.5 | 24.1 | |
Canadian Medical Cannabis(C$M) | 25.8 | 25.3 | 22.5 | 21.8 | 21.2 | 20.0 | 19.6 | 18.7 | 18.8 | 17.7 | 16.9 | 16.2 | |
Storz & Bickel(C$M) | 16.1 | 16.8 | 22.9 | 15.8 | 15.2 | 19.5 | 25.1 | 17.6 | 20.1 | 30.9 | 18.5 | 12.0 | |
Other(C$M) | 0.37 | 0.98 | 1.29 | ||||||||||
This Works(C$M) | 0 | 8.17 | 7.07 | ||||||||||
Earlier reporting (last reported 2025)6 | |||||||||||||
Storz & Bickel(C$M) | 16.1 | 16.8 | 22.9 | 15.8 | 15.2 | 19.5 | 25.1 | 17.6 | 20.1 | 30.9 | 18.5 | 12.0 | |
International Markets Cannabis(C$M) | 9.60 | 8.60 | 6.21 | 5.09 | 8.76 | 5.13 | 8.97 | 8.35 | 8.42 | 2.85 | 10.5 | 8.98 | |
Other(C$M) | 0.37 | 0.98 | 1.29 | ||||||||||
This Work(C$M) | 0 | 8.17 | 7.07 | ||||||||||
Canadian Medical Cannabis1 | |||||||||||||
Canada(C$M) | 3.00 | 2.83 | 2.61 | 2.51 | 2.42 | 2.27 | 2.15 | 2.06 | 2.05 | 1.85 | 1.82 | 1.65 | |
Canadian Adult-use Cannabis1 | |||||||||||||
Canada(C$M) | 16.2 | 10.6 | 13.2 | 13.8 | 14.2 | 10.7 | 9.34 | 8.90 | 7.52 | 8.52 | 9.74 | 10.8 | |
Canada(C$M) | 54.9 | 46.7 | 45.4 | 45.8 | 48.2 | 40.4 | 40.7 | 37.1 | 37.7 | 39.0 | 41.0 | 41.2 | |
Germany(C$M) | 17.6 | 15.8 | 19.2 | 12.7 | 14.4 | 12.4 | 17.7 | 14.2 | 15.5 | 16.9 | 13.5 | 10.1 | |
United States(C$M) | 6.23 | 7.25 | 8.67 | 6.37 | 5.97 | 8.48 | 11.6 | 7.34 | 8.62 | 12.9 | 10.3 | 6.13 | |
Other(C$M) | 2.41 | 1.56 | 1.23 | 1.83 | 3.55 | 3.68 | 4.74 | 4.37 | 4.41 | 4.01 | 13.7 | 12.2 | |
Canada Cannabis(C$M) | 14.5 | 13.0 | 15.9 | 13.6 | -9.01 | 14.1 | 16.2 | 15.3 | 0.30 | 11.3 | 14.3 | ||
Storz & Bickel(C$M) | 7.78 | 4.61 | 8.49 | 6.03 | 4.45 | 7.08 | 9.99 | 5.69 | 7.76 | 11.6 | 9.45 | 3.92 | |
This Works(C$M) | 0 | 4.25 | 3.39 | ||||||||||
Other(C$M) | -0.20 | -0.97 | -0.87 | ||||||||||
Earlier reporting (last reported 2025)2 | |||||||||||||
23 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-07.
See a number that looks wrong?